FDA OTAT Town Hall: Gene Therapy Chemistry, Manufacturing, and Controls – Transcript now available (Cell and Gene Therapy Catapult - Regulatory Round-up – November 2022)
Fiche du document
25 janvier 2023
- handle: 10670/1.kfo8ds
Sujets proches
Therapy, GeneCiter ce document
adelage, « FDA OTAT Town Hall: Gene Therapy Chemistry, Manufacturing, and Controls – Transcript now available (Cell and Gene Therapy Catapult - Regulatory Round-up – November 2022) », ELSIBI, ID : 10670/1.kfo8ds
Métriques
Partage / Export
Résumé
Subject matter experts from the Division of Cell and Gene Therapy at the Office of Tissues and Advanced Therapies (OTAT) within the FDA’s Center for Biologics Evaluation and Research (CBER) hosted a virtual town hall to answer stakeholder questions related to gene therapy chemistry, manufacturing, and controls on Thursday the 29th of September. The transcript is now available here. See all of Catapult's Regulatory Round-up for November 2022 here. Published on the 8th of December 2022.